Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2017

Apr 4, 2017

29875_dirs_2017-04-04_de2ff1ca-0de7-4ceb-b289-4a360a9294b1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2017-04-02

Reporting Person: Foulkes Helena (EVP, President-CVS Pharmacy)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-04-02 Common Stock F 2394 $78.50 Disposed 44996.6533 Direct
2017-04-03 Common Stock (restricted) A 19218 $78.05 Acquired 51191 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-04-03 Stock Option $78.05 A 150268 Acquired 2024-04-03 Common Stock (150268) Direct

Holdings (Non-Derivative)

Security Shares Ownership
ESOP Common Stock 4071.4622 Indirect
Stock Unit 55594.6176 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $34.96 2018-04-01 Common Stock (12058) 12058 Direct
Stock Option $45.07 2019-04-02 Common Stock (19965) 19965 Direct
Stock Option $54.53 2020-04-01 Common Stock (39340) 39340 Direct
Stock Option $34.96 2021-04-01 Common Stock (28607) 28607 Direct
Stock Option $74.29 2021-04-01 Common Stock (52452) 52452 Direct
Stock Option $102.26 2022-04-01 Common Stock (59922) 59922 Direct
Stock Option $104.82 2023-04-01 Common Stock (71696) 71696 Direct

Footnotes

F1: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award.

F2: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022.

F3: Option becomes exercisable in four equal annual installments, commencing 4/3/2018.

F4: Option became exercisable in four equal annual installments, commencing 4/1/2012.

F5: Option became exercisable in four equal annual installments, commencing 4/2/2013.

F6: Option became exercisable in four equal annual installments, commencing 4/1/2014.

F7: Option became exercisable in three equal annual installments, commencing 4/1/2014.

F8: Option became exercisable in four equal annual installments, commencing 4/1/2015.

F9: Option became exercisable in four equal annual installments, commencing 4/1/2016.

F10: Option became exercisable in four equal annual installments, commencing 4/1/2017.